Business Context and Reporting Period
Company: Bruker BioSciences Corporation (formerly Bruker Daltonics Inc.)
Filing Type: Form 8-K (Current Report)
Report Date: August 6, 2003
Reporting Period: Quarter ended June 30, 2003
This filing serves as a notification that the company has announced its results of operations for the second quarter of 2003. The detailed financial data is contained in a press release attached as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The Form 8-K text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being available in the attached press release (Exhibit 99.1) but are not present in the body of this filing document.
Material Changes
No specific material changes or comparative financial data versus the prior period are detailed in the text of this Form 8-K. The filing solely confirms the announcement of the results.
Guidance, Outlook, and Risks
Management Commentary: The filing states that results were announced on August 6, 2003, but does not include specific commentary, guidance, or outlook in the main text.
Risks and Contingencies: No specific risks or contingencies are listed in this document.
Legal Disclaimer: The information furnished in this Form 8-K is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 6, 2003) for actual revenue, earnings, and cash flow figures.
- Verify the specific details of the name change from "Bruker Daltonics Inc." to "Bruker BioSciences Corporation."
- Check subsequent filings for any updates to the financial results announced in this report.